"We serve to accompany you every significant time phasethroughout whole life-cycle of small molecule."
Novel Polymorph ScreeningWith innovative crystallisation technology and platform, we provide our clients with novel polymorph screening or application for their own IP of polymorph.
Non-Infringement Polymorph CustomizationInterpret originator' s polymorph IP and crystalize wanted form in our lab or non-GMP facility, to support our clients in formulation development prior to BE study. Followed by successful completion of formulation development in vitro, we establish and scale up selected crystalline form in GMP facility for in vivo BE purpose.
Novel Synthetic RoutesBy virtue of tight partnership with Chinese Synthesis Innovators, we bring our clients with non-infringement and long-term competitive ROS and Intermediates in the route.
First EnterWe really care about our client to be the first in the market! With this awareness, we support our clients with IP Assessment (non-infringement polymorph, ROS etc.) as well as Quality and Regulatory Affairs. Stable Supply and GMP compliance are always our principles in selecting Primary Supplier Screening.
Last ExitTogether with First Enter Principle, we support our clients to be the last exit in the market by cost saving and alternative source selection. Our Project/Sales Managers have good experience in APIs and Intermediates, which allows them fully understand suppliers' strength in whole industry chain strength and ability of long-term and stable supply .
